Holen Sie sich die Stockscreener-App
1.15
1.71%
-0.02
Handel nachbörslich:
1.18
0.03
+2.61%
Schlusskurs vom Vortag:
$1.17
Offen:
$1.16
24-Stunden-Volumen:
138.78K
Relative Volume:
0.23
Marktkapitalisierung:
$962.82K
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.26M
KGV:
-0.1347
EPS:
-8.54
Netto-Cashflow:
$-8.25M
1W Leistung:
-12.21%
1M Leistung:
-19.01%
6M Leistung:
-86.96%
1J Leistung:
-98.28%
1-Tages-Spanne:
$1.1301
$1.17
1-Wochen-Bereich:
$1.03
$1.3487
52-Wochen-Spanne:
$1.03
$66.00
Oragenics Inc Stock (OGEN) Company Profile
Firmenname
Oragenics Inc
Sektor
Branche
Telefon
813-286-7900
Adresse
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Vergleichen Sie OGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
1.15 | 962.82K | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Oragenics Inc Aktie (OGEN) Neueste Nachrichten
Tools to assess Oragenics Inc.’s risk profileWeekly Risk Report & High Conviction Trade Alerts - Newser
What to do if you’re stuck in Oragenics Inc.2025 Historical Comparison & Stock Market Timing Techniques - Newser
How sentiment analysis helps forecast Oragenics Inc.Earnings Trend Report & Capital Efficient Trade Techniques - Newser
Published on: 2025-08-12 22:56:34 - Newser
Has Oragenics Inc. found a price floorFree Strong Buy With Technical Confidence - Newser
Smart tools for monitoring Oragenics Inc.’s price actionPrice Action Summary and Entry Strategy Guide - Newser
Backtesting results for Oragenics Inc. trading strategiesReal-Time Entry Forecast with Accuracy Metrics - Newser
Real time social sentiment graph for Oragenics Inc.Daily Equity Signal Strength Summary Report - Newser
What makes Oragenics Inc. stock price move sharplyFree Price Breakout Alerts - thegnnews.com
Oragenics Inc. Advances ONP-002 Toward Phase IIa Concussion Trial with Strategic Q2 2025 Milestones - citybuzz -
Oragenics advances toward phase IIa trials for concussion treatment - Investing.com
Oragenics Q2 2025 Shareholder Update - GlobeNewswire
Oragenics Advances Brain-First Recovery Platform Toward Clinical Milestones. - AInvest
Strategies to average down on Oragenics Inc.Free Fast Return Equity Trade Forecast - Newser
Oragenics Inc. stock trend forecastConservative Asset Allocation Risk Analysis - Newser
Is this a good reentry point in Oragenics Inc.Free Daily Stock Market Swing Alerts - Newser
Using fundamentals and technicals on Oragenics Inc.Buy Alert Based on RSI and Volume - Newser
How Oragenics Inc. stock performs during market volatilityLow Drawdown Stock Screener with Analysis - Newser
Is Oragenics Inc. a strong growth stockExplosive Potential Mid Cap Picks - mustnews.co.kr
Will Oragenics Inc. outperform the market in YEARReversal Pattern Breakout Alerts - mustnews.co.kr
Quantitative breakdown of Oragenics Inc. recent moveFree Stock Market Watch With Alerts - Newser
Can Oragenics Inc. maintain sales growthBig Profit Trading Alerts - mustnews.co.kr
Published on: 2025-08-09 21:31:02 - Newser
Evaluating Oragenics Inc. with trendline analysisFast Entry Strategy with Price Prediction - Newser
Oragenics: Q2 Earnings Snapshot - San Antonio Express-News
Live market analysis of Oragenics Inc.Daily Market Movers Screener with Filters - Newser
Building trade automation scripts for Oragenics Inc.AI Trade Signal Forecast with Chart Logic - Newser
Oragenics Inc. Stock Performance After Earnings: Historical InsightsFree Low Drawdown Real Time Trading Tips - Newser
Chart overlay techniques for tracking Oragenics Inc.Free Triple Return Setup with Risk Control - Newser
Real time breakdown of Oragenics Inc. stock performanceAnnual Market Behavior and Sector Summary - Newser
Finanzdaten der Oragenics Inc-Aktie (OGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):